Scott Rocklage has a PhD in Chemistry from the Massachusetts Institute of Technology and a BS in Chemistry from the University of California Berkeley. Read more: Scott Racklage | Bloomberg
He also has served as a board member for many organizations. Some of those are: Chairman for Novira Therapeutics Inc., Director for Rennovia Inc, and Chairman of the Board for Cidara Therapeutics Inc. He has over 25 years of experience with management in the healthcare field and has also gotten 3 different drug applications approved by the FDA. Learn more about Scott Rocklage: http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY
Those applications were for: Omniscan, Cubicin, and Teslascan. Additionally, he has been able to put 6 different possible drugs into clinical trials. He is also either to inventor or co-inventor of over 30 different United States patents and has more than 100 publications that are peer-reviewed. As of right now, he is based out of Boston, Massachusetts.
In 2003, Scott Rocklage joined 5AM Ventures. He started out as just a Venture Partner and in 2004 he moved up to Managing Partner. The way 5AM Ventures works is by working with other professionals, including pharmacists, doctors, and scientists, to come up with ideas on drugs that can help treat and cure conditions that don’t currently have good medications for these things.
The main things that he believes needs to be done in order to start a successful business are: don’t be afraid to take risks that are within reason and don’t be afraid to hire new people if you realize the original person you hired just isn’t working.
He believes that, if you set your mind to it, then you can accomplish it and you won’t know how it will turn out if you don’t try.
The Evolution of Smooth is a company that people are taking a lot of interest in. It has become the talk of the town on Pinterest, Facebook, Twitter and Instagram. There are pictures posted of celebrities that are utilizing this lip balm. Friends are showing how to decorate using this lip balm. It has become used in so many different circles that it is just common place for people to buy this lip balm out of habit.
Everyone is talking about it, and it is hard to overlook when people are in stores. It has become the impulse buy that gets a ton of attention because it is designed to help people that really want to come up with colorful decorating ideas for certain party events. Lip balm has been used for a long time for chapped lips, but it is something new for these types of products to be used for decorating. This is something out of the ordinary, but that may be the thing that has made the Evolution of Smooth lip balm containers stand out the most.
The flavors are also attention-getting as well. It is hard to compete against a company like the Evolution of Smooth. This company has executives in place that know the value of flavorful lip balm, and they are taking every opportunity to make sure that customers have this. It is evident that this is part of the equation when it comes to selling lip balm to a mainstream audience, great review here.
People are very enticed with the flavors and the shape of their containers. It is a very lively product that connected with a youthful generation that wanted something different. So many people are tired of the same mundane lip balm products. He has helped change the monotony in the lip balm industry.
In America, oil executives are perceived as greedy individuals who do not care about the well being of other people. Through his hard work and achievements, Tony Petrello has proved that this perception is just a misconception. Tony is the president and CEO of Nabors Industries, the largest drilling contractor worldwide. The oil executive has demonstrated his kindness by supporting various charitable activities in the society. Recently, Tony and his wife Cynthia committed $7 million towards an initiative that seeks to help children suffering from neurological disorders at the Texas Children’s Hospital. The couple’s child, who was diagnosed with neurological disorder, inspired them to support other children with the similar disease.
Tony Petrello’s eight-year-old daughter Carena was born at 5 months and diagnosed with periventricular leukemia, a neurological disease common in premature infants. To this end, Carena developed cerebral palsy, which is accompanied by delayed development. The condition is caused by insufficient oxygen to the brain. Over the years, the Tony and Cynthia have visited different hospitals to search for cure for their beloved daughter. Carena is now learning different activities like talking, walking, and eating. Tony’s search for cure from various pediatric research institutions made him realize the need for a large scale research to find cure for this condition in children. With the launch of the Neurological Research Institute (NRI) at Texas Children’s Hospital, Tony believes that Carena and other children across the world will find cure. Presently, Tony advocates for research and clinical programs at NRI.
Tony Petrello joined Nabors Industries in 1991 to render his services on the board of directors and the executive committee. Over the years, he has worked in several positions at the company, including being the chief operating officer, deputy chairman, and chairman of the board and the executive committee. In his current role, Tony Petrello works to ensure that Nabors Industries thrives in the highly competitive environment. He offers guidance on strategic planning. Before joining Nabors, Tony worked for a renowned a law firm, Baker & McKenzie, where he practiced international arbitration, general corporate law and taxation. In addition, he rendered his services for the firm’s New York office as the managing partner. Petrello is an alumnus of Harvard Law School where he earned a J.D. degree. Moreover, he earned his M.S. and graduated with a B.S. degree in mathematics from Yale University. Stewart & Stevenson LLC and Hilcorp Energy Company were impressed by his success. This way, Tony serves as a director of each of these corporations.